Drug interactions for the following drug(s)
Applies to: Spironolactone 25 MG Oral Tablet <> Macrobid 100 MG Oral Capsule
Nitrofurantoin may increase the hyperkalemic activities of Spironolactone.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> Ondansetron 8 MG Oral Tablet
The metabolism of Ondansetron can be decreased when combined with Metoprolol.
Applies to: omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet <> clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Omeprazole resulting in a loss in efficacy.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Spironolactone 25 MG Oral Tablet
Spironolactone may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy.
The metabolism of Clopidogrel can be decreased when combined with Fluticasone propionate.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution
Acetaminophen may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet
The risk or severity of adverse effects can be increased when Oxycodone is combined with Fentanyl.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Spironolactone 25 MG Oral Tablet
The therapeutic efficacy of Salbutamol can be decreased when used in combination with Spironolactone.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Ondansetron 8 MG Oral Tablet
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ondansetron.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Ondansetron 8 MG Oral Tablet
The metabolism of Acetaminophen can be decreased when combined with Ondansetron.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> fentaNYL 25 MCG/HR 72HR Transdermal System
Fentanyl may decrease the excretion rate of Acetylsalicylic acid which could result in a higher serum level.
Applies to: Lipitor 80 MG Oral Tablet <> Macrobid 100 MG Oral Capsule
Nitrofurantoin may decrease the excretion rate of Atorvastatin which could result in a higher serum level.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> Spironolactone 25 MG Oral Tablet
Metoprolol may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> aspirin 81 MG Enteric Coated Oral Tablet
Acetylsalicylic acid may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Metoprolol Tartrate 50 MG Oral Tablet
Acetylsalicylic acid may decrease the antihypertensive activities of Metoprolol.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet
The metabolism of Clonidine can be increased when combined with Omeprazole.
Applies to: Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT <> Macrobid 100 MG Oral Capsule
The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Fluticasone propionate.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet
The metabolism of Oxycodone can be decreased when combined with Metoprolol.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> Spironolactone 25 MG Oral Tablet
Spironolactone may increase the excretion rate of Fentanyl which could result in a lower serum level and potentially a reduction in efficacy.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> Ondansetron 8 MG Oral Tablet
The risk or severity of adverse effects can be increased when Fentanyl is combined with Ondansetron.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Levofloxacin 500 MG Oral Tablet
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Levofloxacin.
Applies to: clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet <> Lipitor 80 MG Oral Tablet
The metabolism of Clopidogrel can be decreased when combined with Atorvastatin.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet
Fentanyl can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Levofloxacin 500 MG Oral Tablet
The metabolism of Acetaminophen can be decreased when combined with Levofloxacin.
Applies to: Ondansetron 8 MG Oral Tablet <> Levofloxacin 500 MG Oral Tablet
The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Levofloxacin.
Applies to: Macrobid 100 MG Oral Capsule <> Levofloxacin 500 MG Oral Tablet
The therapeutic efficacy of Levofloxacin can be decreased when used in combination with Nitrofurantoin.
Applies to: Macrobid 100 MG Oral Capsule <> Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Fluticasone furoate.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> Spironolactone 25 MG Oral Tablet
The therapeutic efficacy of Clonidine can be decreased when used in combination with Spironolactone.
Applies to: Macrobid 100 MG Oral Capsule <> omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet
Omeprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
The metabolism of Metoprolol can be decreased when combined with Fluticasone propionate.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet
The metabolism of Metoprolol can be increased when combined with Omeprazole.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Methylprednisolone 4 MG Oral Tablet
The risk or severity of gastrointestinal irritation can be increased when Acetylsalicylic acid is combined with Methylprednisolone.
Applies to: omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet <> Ondansetron 8 MG Oral Tablet
The metabolism of Ondansetron can be decreased when combined with Omeprazole.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> Ondansetron 8 MG Oral Tablet
The risk or severity of sedation can be increased when Clonidine is combined with Ondansetron.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> Levofloxacin 500 MG Oral Tablet
Fentanyl may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> Metoprolol Tartrate 50 MG Oral Tablet
Fentanyl may decrease the antihypertensive activities of Metoprolol.
The metabolism of Salmeterol can be decreased when combined with Fentanyl.
Applies to: Ondansetron 8 MG Oral Tablet <> clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet
The metabolism of Clopidogrel can be decreased when combined with Ondansetron.
Applies to: clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet <> Levofloxacin 500 MG Oral Tablet
The metabolism of Clopidogrel can be decreased when combined with Levofloxacin.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> fentaNYL 25 MCG/HR 72HR Transdermal System
The metabolism of Fentanyl can be decreased when combined with Acetaminophen.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Spironolactone 25 MG Oral Tablet
Acetylsalicylic acid may decrease the excretion rate of Spironolactone which could result in a higher serum level.
Applies to: omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet <> oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet
The metabolism of Oxycodone can be decreased when combined with Omeprazole.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet
The metabolism of Clopidogrel can be decreased when combined with Clonidine.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet
Oxycodone can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Ondansetron 8 MG Oral Tablet
The metabolism of Acetylsalicylic acid can be decreased when combined with Ondansetron.
Applies to: omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet <> Spironolactone 25 MG Oral Tablet
The metabolism of Omeprazole can be decreased when combined with Spironolactone.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Clonidine Hydrochloride 0.3 MG Oral Tablet
Acetylsalicylic acid may decrease the antihypertensive activities of Clonidine.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> Methylprednisolone 4 MG Oral Tablet
The metabolism of Clonidine can be increased when combined with Methylprednisolone.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Lipitor 80 MG Oral Tablet
The metabolism of Atorvastatin can be decreased when combined with Oxycodone.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> Lipitor 80 MG Oral Tablet
The metabolism of Atorvastatin can be decreased when combined with Clonidine.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> fentaNYL 25 MCG/HR 72HR Transdermal System
The risk or severity of sedation can be increased when Clonidine is combined with Fentanyl.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Methylprednisolone 4 MG Oral Tablet
The risk or severity of hypokalemia can be increased when Methylprednisolone is combined with Salbutamol.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> Levofloxacin 500 MG Oral Tablet
Metoprolol may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet
The metabolism of Fentanyl can be decreased when combined with Omeprazole.
Applies to: Ondansetron 8 MG Oral Tablet <> Lipitor 80 MG Oral Tablet
The metabolism of Atorvastatin can be decreased when combined with Ondansetron.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Macrobid 100 MG Oral Capsule
The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Nitrofurantoin.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Metoprolol Tartrate 50 MG Oral Tablet
The therapeutic efficacy of Salbutamol can be decreased when used in combination with Metoprolol.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Clonidine Hydrochloride 0.3 MG Oral Tablet
The metabolism of Clonidine can be increased when combined with Acetaminophen.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Clonidine Hydrochloride 0.3 MG Oral Tablet
Salbutamol may decrease the antihypertensive activities of Clonidine.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> fentaNYL 25 MCG/HR 72HR Transdermal System
The risk or severity of hypertension can be increased when Fentanyl is combined with Salbutamol.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Levofloxacin 500 MG Oral Tablet
Acetylsalicylic acid may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Applies to: Spironolactone 25 MG Oral Tablet <> Lipitor 80 MG Oral Tablet
The metabolism of Atorvastatin can be decreased when combined with Spironolactone.
Applies to: Levofloxacin 500 MG Oral Tablet <> Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
The risk or severity of tendinopathy can be increased when Levofloxacin is combined with Fluticasone furoate.
The metabolism of Omeprazole can be decreased when combined with Fluticasone furoate.
The risk or severity of hypertension can be increased when Salmeterol is combined with Acetylsalicylic acid.
Applies to: omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet <> Lipitor 80 MG Oral Tablet
The metabolism of Atorvastatin can be decreased when combined with Omeprazole.
Applies to: Macrobid 100 MG Oral Capsule <> Spironolactone 25 MG Oral Tablet
Nitrofurantoin may increase the hyperkalemic activities of Spironolactone.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> Macrobid 100 MG Oral Capsule
Nitrofurantoin may decrease the excretion rate of Fentanyl which could result in a higher serum level.
Applies to: Lipitor 80 MG Oral Tablet <> Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
The metabolism of Atorvastatin can be decreased when combined with Fluticasone furoate.
Applies to: Macrobid 100 MG Oral Capsule <> Lipitor 80 MG Oral Tablet
Nitrofurantoin may decrease the excretion rate of Atorvastatin which could result in a higher serum level.
The metabolism of Atorvastatin can be decreased when combined with Salmeterol.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> Macrobid 100 MG Oral Capsule
The risk or severity of hyperkalemia can be increased when Metoprolol is combined with Nitrofurantoin.
Applies to: Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT <> Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluticasone.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> Levofloxacin 500 MG Oral Tablet
The metabolism of Clonidine can be decreased when combined with Levofloxacin.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet
The risk or severity of sedation can be increased when Clonidine is combined with Oxycodone.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet
The metabolism of Acetaminophen can be increased when combined with Omeprazole.
Applies to: Spironolactone 25 MG Oral Tablet <> Levofloxacin 500 MG Oral Tablet
Spironolactone may increase the excretion rate of Levofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> Lipitor 80 MG Oral Tablet
The metabolism of Atorvastatin can be decreased when combined with Fentanyl.
Applies to: Methylprednisolone 4 MG Oral Tablet <> Metoprolol Tartrate 50 MG Oral Tablet
The metabolism of Metoprolol can be increased when combined with Methylprednisolone.
Applies to: Methylprednisolone 4 MG Oral Tablet <> Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Fluticasone.
The therapeutic efficacy of Salmeterol can be decreased when used in combination with Spironolactone.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Macrobid 100 MG Oral Capsule
Acetylsalicylic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Ondansetron.
The risk or severity of hypokalemia can be increased when Fluticasone is combined with Salbutamol.
Applies to: omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet <> Macrobid 100 MG Oral Capsule
Omeprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Applies to: Methylprednisolone 4 MG Oral Tablet <> Levofloxacin 500 MG Oral Tablet
The risk or severity of tendinopathy can be increased when Levofloxacin is combined with Methylprednisolone.
The risk or severity of tendinopathy can be increased when Levofloxacin is combined with Fluticasone.
The metabolism of Oxycodone can be decreased when combined with Fluticasone furoate.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Macrobid 100 MG Oral Capsule
Nitrofurantoin may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> Metoprolol Tartrate 50 MG Oral Tablet
The risk or severity of hypotension can be increased when Clonidine is combined with Metoprolol.
The metabolism of Clonidine can be decreased when combined with Salmeterol.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Metoprolol Tartrate 50 MG Oral Tablet
The metabolism of Metoprolol can be decreased when combined with Acetaminophen.
Applies to: Levofloxacin 500 MG Oral Tablet <> Macrobid 100 MG Oral Capsule
The therapeutic efficacy of Levofloxacin can be decreased when used in combination with Nitrofurantoin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Spironolactone 25 MG Oral Tablet <> Macrobid 100 MG Oral Capsule
Drug1 (rxcui = 313096, name = spironolactone 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug1 is resolved to spironolactone, Drug2 is resolved to nitrofurantoin, macrocrystals and interaction asserted in DrugBank between Spironolactone and Nitrofurantoin.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> Ondansetron 8 MG Oral Tablet
Drug1 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 312086, name = ondansetron 8 MG Oral Tablet, tty = SCD). Drug1 is resolved to metoprolol, Drug2 is resolved to ondansetron and interaction asserted in DrugBank between Metoprolol and Ondansetron.
Applies to: omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet <> clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet
Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 309362, name = clopidogrel 75 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to clopidogrel and interaction asserted in DrugBank between Omeprazole and Clopidogrel.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Spironolactone 25 MG Oral Tablet
Drug1 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 313096, name = spironolactone 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to acetaminophen, Drug2 is resolved to spironolactone and interaction asserted in DrugBank between Acetaminophen and Spironolactone. Drug1 is resolved to oxycodone, Drug2 is resolved to spironolactone and interaction asserted in DrugBank between Oxycodone and Spironolactone.
Drug1 (rxcui = 309362, name = clopidogrel 75 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to clopidogrel, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Clopidogrel and Fluticasone propionate. Drug1 is resolved to clopidogrel, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Clopidogrel and Salmeterol. Drug1 is resolved to clopidogrel, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Clopidogrel and Fluticasone. Drug1 is resolved to clopidogrel, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Clopidogrel and Fluticasone furoate.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution
Drug1 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug1 is resolved to acetaminophen, Drug2 is resolved to albuterol and interaction asserted in DrugBank between Acetaminophen and Salbutamol.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet
Drug1 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug2 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to fentanyl, Drug2 is resolved to oxycodone and interaction asserted in DrugBank between Fentanyl and Oxycodone.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Spironolactone 25 MG Oral Tablet
Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 313096, name = spironolactone 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to spironolactone and interaction asserted in DrugBank between Salbutamol and Spironolactone.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Ondansetron 8 MG Oral Tablet
Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 312086, name = ondansetron 8 MG Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to ondansetron and interaction asserted in DrugBank between Salbutamol and Ondansetron.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Ondansetron 8 MG Oral Tablet
Drug1 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 312086, name = ondansetron 8 MG Oral Tablet, tty = SCD). Drug1 is resolved to acetaminophen, Drug2 is resolved to ondansetron and interaction asserted in DrugBank between Acetaminophen and Ondansetron. Drug1 is resolved to oxycodone, Drug2 is resolved to ondansetron and interaction asserted in DrugBank between Oxycodone and Ondansetron.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> fentaNYL 25 MCG/HR 72HR Transdermal System
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to fentanyl and interaction asserted in DrugBank between Acetylsalicylic acid and Fentanyl.
Applies to: Lipitor 80 MG Oral Tablet <> Macrobid 100 MG Oral Capsule
Drug1 (rxcui = 262095, name = atorvastatin 80 MG Oral Tablet [Lipitor], tty = SBD). Drug2 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug1 is resolved to atorvastatin, Drug2 is resolved to nitrofurantoin, macrocrystals and interaction asserted in DrugBank between Atorvastatin and Nitrofurantoin.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> Spironolactone 25 MG Oral Tablet
Drug1 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 313096, name = spironolactone 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to metoprolol, Drug2 is resolved to spironolactone and interaction asserted in DrugBank between Metoprolol and Spironolactone.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> aspirin 81 MG Enteric Coated Oral Tablet
Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to aspirin and interaction asserted in DrugBank between Salbutamol and Acetylsalicylic acid.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Metoprolol Tartrate 50 MG Oral Tablet
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Acetylsalicylic acid and Metoprolol.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet
Drug1 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to clonidine, Drug2 is resolved to omeprazole and interaction asserted in DrugBank between Clonidine and Omeprazole.
Applies to: Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT <> Macrobid 100 MG Oral Capsule
Drug1 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug2 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug1 is resolved to fluticasone propionate, Drug2 is resolved to nitrofurantoin, macrocrystals and interaction asserted in DrugBank between Fluticasone propionate and Nitrofurantoin.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet
Drug1 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to metoprolol, Drug2 is resolved to oxycodone and interaction asserted in DrugBank between Metoprolol and Oxycodone.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> Spironolactone 25 MG Oral Tablet
Drug1 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug2 (rxcui = 313096, name = spironolactone 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to fentanyl, Drug2 is resolved to spironolactone and interaction asserted in DrugBank between Fentanyl and Spironolactone.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> Ondansetron 8 MG Oral Tablet
Drug1 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug2 (rxcui = 312086, name = ondansetron 8 MG Oral Tablet, tty = SCD). Drug1 is resolved to fentanyl, Drug2 is resolved to ondansetron and interaction asserted in DrugBank between Fentanyl and Ondansetron.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Levofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Salbutamol and Levofloxacin. Drug1 is resolved to albuterol, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Salbutamol and Levofloxacin.
Applies to: clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet <> Lipitor 80 MG Oral Tablet
Drug1 (rxcui = 309362, name = clopidogrel 75 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 262095, name = atorvastatin 80 MG Oral Tablet [Lipitor], tty = SBD). Drug1 is resolved to clopidogrel, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Clopidogrel and Atorvastatin.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet
Drug1 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug2 (rxcui = 309362, name = clopidogrel 75 MG Oral Tablet, tty = SCD). Drug1 is resolved to fentanyl, Drug2 is resolved to clopidogrel and interaction asserted in DrugBank between Fentanyl and Clopidogrel.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Levofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to acetaminophen, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Acetaminophen and Levofloxacin. Drug1 is resolved to acetaminophen, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Acetaminophen and Levofloxacin.
Applies to: Ondansetron 8 MG Oral Tablet <> Levofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 312086, name = ondansetron 8 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to ondansetron, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Ondansetron and Levofloxacin. Drug1 is resolved to ondansetron, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Ondansetron and Levofloxacin.
Applies to: Macrobid 100 MG Oral Capsule <> Levofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug2 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to nitrofurantoin, macrocrystals, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Nitrofurantoin and Levofloxacin. Drug1 is resolved to nitrofurantoin, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Nitrofurantoin and Levofloxacin. Drug1 is resolved to nitrofurantoin, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Nitrofurantoin and Levofloxacin.
Applies to: Macrobid 100 MG Oral Capsule <> Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
Drug1 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to nitrofurantoin, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Nitrofurantoin and Fluticasone furoate. Drug1 is resolved to nitrofurantoin, macrocrystals, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Nitrofurantoin and Fluticasone furoate. Drug1 is resolved to nitrofurantoin, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Nitrofurantoin and Fluticasone propionate.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> Spironolactone 25 MG Oral Tablet
Drug1 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 313096, name = spironolactone 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to clonidine, Drug2 is resolved to spironolactone and interaction asserted in DrugBank between Clonidine and Spironolactone.
Applies to: Macrobid 100 MG Oral Capsule <> omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet
Drug1 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to nitrofurantoin, Drug2 is resolved to omeprazole and interaction asserted in DrugBank between Nitrofurantoin and Omeprazole.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
Drug1 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to metoprolol, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Metoprolol and Fluticasone propionate. Drug1 is resolved to metoprolol, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Metoprolol and Fluticasone. Drug1 is resolved to metoprolol, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Metoprolol and Salmeterol. Drug1 is resolved to metoprolol, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Metoprolol and Fluticasone furoate.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet
Drug1 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to metoprolol, Drug2 is resolved to omeprazole and interaction asserted in DrugBank between Metoprolol and Omeprazole.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Methylprednisolone 4 MG Oral Tablet
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 259966, name = methylprednisolone 4 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to methylprednisolone and interaction asserted in DrugBank between Acetylsalicylic acid and Methylprednisolone.
Applies to: omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet <> Ondansetron 8 MG Oral Tablet
Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 312086, name = ondansetron 8 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to ondansetron and interaction asserted in DrugBank between Omeprazole and Ondansetron.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> Ondansetron 8 MG Oral Tablet
Drug1 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 312086, name = ondansetron 8 MG Oral Tablet, tty = SCD). Drug1 is resolved to clonidine, Drug2 is resolved to ondansetron and interaction asserted in DrugBank between Clonidine and Ondansetron.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> Levofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug2 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to fentanyl, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Fentanyl and Levofloxacin. Drug1 is resolved to fentanyl, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Fentanyl and Levofloxacin.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> Metoprolol Tartrate 50 MG Oral Tablet
Drug1 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug2 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to fentanyl, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Fentanyl and Metoprolol.
Drug1 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to fentanyl, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Fentanyl and Salmeterol. Drug1 is resolved to fentanyl, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fentanyl and Fluticasone propionate. Drug1 is resolved to fentanyl, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fentanyl and Fluticasone. Drug1 is resolved to fentanyl, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fentanyl and Fluticasone furoate.
Applies to: Ondansetron 8 MG Oral Tablet <> clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet
Drug1 (rxcui = 312086, name = ondansetron 8 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 309362, name = clopidogrel 75 MG Oral Tablet, tty = SCD). Drug1 is resolved to ondansetron, Drug2 is resolved to clopidogrel and interaction asserted in DrugBank between Ondansetron and Clopidogrel.
Applies to: clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet <> Levofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 309362, name = clopidogrel 75 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to clopidogrel, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Clopidogrel and Levofloxacin. Drug1 is resolved to clopidogrel, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Clopidogrel and Levofloxacin.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> fentaNYL 25 MCG/HR 72HR Transdermal System
Drug1 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug1 is resolved to acetaminophen, Drug2 is resolved to fentanyl and interaction asserted in DrugBank between Acetaminophen and Fentanyl.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Spironolactone 25 MG Oral Tablet
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 313096, name = spironolactone 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to spironolactone and interaction asserted in DrugBank between Acetylsalicylic acid and Spironolactone.
Applies to: omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet <> oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet
Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to oxycodone and interaction asserted in DrugBank between Omeprazole and Oxycodone.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet
Drug1 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 309362, name = clopidogrel 75 MG Oral Tablet, tty = SCD). Drug1 is resolved to clonidine, Drug2 is resolved to clopidogrel and interaction asserted in DrugBank between Clonidine and Clopidogrel.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet
Drug1 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 309362, name = clopidogrel 75 MG Oral Tablet, tty = SCD). Drug1 is resolved to oxycodone, Drug2 is resolved to clopidogrel and interaction asserted in DrugBank between Oxycodone and Clopidogrel. Drug1 is resolved to acetaminophen, Drug2 is resolved to clopidogrel and interaction asserted in DrugBank between Acetaminophen and Clopidogrel.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Ondansetron 8 MG Oral Tablet
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 312086, name = ondansetron 8 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to ondansetron and interaction asserted in DrugBank between Acetylsalicylic acid and Ondansetron.
Applies to: omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet <> Spironolactone 25 MG Oral Tablet
Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 313096, name = spironolactone 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to spironolactone and interaction asserted in DrugBank between Omeprazole and Spironolactone.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Clonidine Hydrochloride 0.3 MG Oral Tablet
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to clonidine and interaction asserted in DrugBank between Acetylsalicylic acid and Clonidine.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> Methylprednisolone 4 MG Oral Tablet
Drug1 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 259966, name = methylprednisolone 4 MG Oral Tablet, tty = SCD). Drug1 is resolved to clonidine, Drug2 is resolved to methylprednisolone and interaction asserted in DrugBank between Clonidine and Methylprednisolone.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Lipitor 80 MG Oral Tablet
Drug1 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 262095, name = atorvastatin 80 MG Oral Tablet [Lipitor], tty = SBD). Drug1 is resolved to oxycodone, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Oxycodone and Atorvastatin. Drug1 is resolved to acetaminophen, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Acetaminophen and Atorvastatin.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> Lipitor 80 MG Oral Tablet
Drug1 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 262095, name = atorvastatin 80 MG Oral Tablet [Lipitor], tty = SBD). Drug1 is resolved to clonidine, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Clonidine and Atorvastatin.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> fentaNYL 25 MCG/HR 72HR Transdermal System
Drug1 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug1 is resolved to clonidine, Drug2 is resolved to fentanyl and interaction asserted in DrugBank between Clonidine and Fentanyl.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Methylprednisolone 4 MG Oral Tablet
Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 259966, name = methylprednisolone 4 MG Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to methylprednisolone and interaction asserted in DrugBank between Salbutamol and Methylprednisolone.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> Levofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to metoprolol, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Metoprolol and Levofloxacin. Drug1 is resolved to metoprolol, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Metoprolol and Levofloxacin.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet
Drug1 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to fentanyl, Drug2 is resolved to omeprazole and interaction asserted in DrugBank between Fentanyl and Omeprazole.
Applies to: Ondansetron 8 MG Oral Tablet <> Lipitor 80 MG Oral Tablet
Drug1 (rxcui = 312086, name = ondansetron 8 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 262095, name = atorvastatin 80 MG Oral Tablet [Lipitor], tty = SBD). Drug1 is resolved to ondansetron, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Ondansetron and Atorvastatin.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Macrobid 100 MG Oral Capsule
Drug1 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug1 is resolved to acetaminophen, Drug2 is resolved to nitrofurantoin and interaction asserted in DrugBank between Acetaminophen and Nitrofurantoin. Drug1 is resolved to acetaminophen, Drug2 is resolved to nitrofurantoin, macrocrystals and interaction asserted in DrugBank between Acetaminophen and Nitrofurantoin.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Metoprolol Tartrate 50 MG Oral Tablet
Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Salbutamol and Metoprolol.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Clonidine Hydrochloride 0.3 MG Oral Tablet
Drug1 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug1 is resolved to acetaminophen, Drug2 is resolved to clonidine and interaction asserted in DrugBank between Acetaminophen and Clonidine.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Clonidine Hydrochloride 0.3 MG Oral Tablet
Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to clonidine and interaction asserted in DrugBank between Salbutamol and Clonidine.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> fentaNYL 25 MCG/HR 72HR Transdermal System
Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to fentanyl and interaction asserted in DrugBank between Salbutamol and Fentanyl.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Levofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Acetylsalicylic acid and Levofloxacin. Drug1 is resolved to aspirin, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Acetylsalicylic acid and Levofloxacin.
Applies to: Spironolactone 25 MG Oral Tablet <> Lipitor 80 MG Oral Tablet
Drug1 (rxcui = 313096, name = spironolactone 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 262095, name = atorvastatin 80 MG Oral Tablet [Lipitor], tty = SBD). Drug1 is resolved to spironolactone, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Spironolactone and Atorvastatin.
Applies to: Levofloxacin 500 MG Oral Tablet <> Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
Drug1 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to levofloxacin, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Levofloxacin and Fluticasone furoate.
Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to omeprazole, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Omeprazole and Fluticasone furoate. Drug1 is resolved to omeprazole, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Omeprazole and Fluticasone. Drug1 is resolved to omeprazole, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Omeprazole and Salmeterol. Drug1 is resolved to omeprazole, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Omeprazole and Fluticasone propionate.
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to aspirin, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Acetylsalicylic acid and Salmeterol. Drug1 is resolved to aspirin, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Acetylsalicylic acid and Fluticasone propionate. Drug1 is resolved to aspirin, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Acetylsalicylic acid and Fluticasone. Drug1 is resolved to aspirin, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Acetylsalicylic acid and Fluticasone furoate.
Applies to: omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet <> Lipitor 80 MG Oral Tablet
Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 262095, name = atorvastatin 80 MG Oral Tablet [Lipitor], tty = SBD). Drug1 is resolved to omeprazole, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Omeprazole and Atorvastatin.
Applies to: Macrobid 100 MG Oral Capsule <> Spironolactone 25 MG Oral Tablet
Drug1 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug2 (rxcui = 313096, name = spironolactone 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to nitrofurantoin, Drug2 is resolved to spironolactone and interaction asserted in DrugBank between Nitrofurantoin and Spironolactone.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> Macrobid 100 MG Oral Capsule
Drug1 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug2 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug1 is resolved to fentanyl, Drug2 is resolved to nitrofurantoin and interaction asserted in DrugBank between Fentanyl and Nitrofurantoin. Drug1 is resolved to fentanyl, Drug2 is resolved to nitrofurantoin, macrocrystals and interaction asserted in DrugBank between Fentanyl and Nitrofurantoin.
Applies to: Lipitor 80 MG Oral Tablet <> Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
Drug1 (rxcui = 262095, name = atorvastatin 80 MG Oral Tablet [Lipitor], tty = SBD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to atorvastatin, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Atorvastatin and Fluticasone furoate.
Applies to: Macrobid 100 MG Oral Capsule <> Lipitor 80 MG Oral Tablet
Drug1 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug2 (rxcui = 262095, name = atorvastatin 80 MG Oral Tablet [Lipitor], tty = SBD). Drug1 is resolved to nitrofurantoin, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Nitrofurantoin and Atorvastatin.
Drug1 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug2 (rxcui = 262095, name = atorvastatin 80 MG Oral Tablet [Lipitor], tty = SBD). Drug1 is resolved to salmeterol, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Salmeterol and Atorvastatin. Drug1 is resolved to fluticasone, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Fluticasone and Atorvastatin. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Fluticasone propionate and Atorvastatin.
Applies to: Metoprolol Tartrate 50 MG Oral Tablet <> Macrobid 100 MG Oral Capsule
Drug1 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug1 is resolved to metoprolol, Drug2 is resolved to nitrofurantoin, macrocrystals and interaction asserted in DrugBank between Metoprolol and Nitrofurantoin. Drug1 is resolved to metoprolol, Drug2 is resolved to nitrofurantoin and interaction asserted in DrugBank between Metoprolol and Nitrofurantoin.
Applies to: Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT <> Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
Drug1 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone. Drug1 is resolved to salmeterol, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Salmeterol and Fluticasone. Drug1 is resolved to fluticasone, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Fluticasone and Salmeterol. Drug1 is resolved to salmeterol, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Salmeterol and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Fluticasone furoate and Salmeterol. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone propionate. Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone and Fluticasone propionate. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> Levofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to clonidine, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Clonidine and Levofloxacin. Drug1 is resolved to clonidine, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Clonidine and Levofloxacin.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet
Drug1 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to clonidine, Drug2 is resolved to oxycodone and interaction asserted in DrugBank between Clonidine and Oxycodone.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet
Drug1 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to acetaminophen, Drug2 is resolved to omeprazole and interaction asserted in DrugBank between Acetaminophen and Omeprazole.
Applies to: Spironolactone 25 MG Oral Tablet <> Levofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 313096, name = spironolactone 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to spironolactone, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Spironolactone and Levofloxacin. Drug1 is resolved to spironolactone, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Spironolactone and Levofloxacin.
Applies to: fentaNYL 25 MCG/HR 72HR Transdermal System <> Lipitor 80 MG Oral Tablet
Drug1 (rxcui = 245134, name = 72 HR fentanyl 0.025 MG/HR Transdermal System, tty = SCD). Drug2 (rxcui = 262095, name = atorvastatin 80 MG Oral Tablet [Lipitor], tty = SBD). Drug1 is resolved to fentanyl, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Fentanyl and Atorvastatin.
Applies to: Methylprednisolone 4 MG Oral Tablet <> Metoprolol Tartrate 50 MG Oral Tablet
Drug1 (rxcui = 259966, name = methylprednisolone 4 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to methylprednisolone, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Methylprednisolone and Metoprolol.
Applies to: Methylprednisolone 4 MG Oral Tablet <> Advair Diskus 100/50 (fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
Drug1 (rxcui = 259966, name = methylprednisolone 4 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to methylprednisolone, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Methylprednisolone and Fluticasone. Drug1 is resolved to methylprednisolone, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Methylprednisolone and Salmeterol. Drug1 is resolved to methylprednisolone, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Methylprednisolone and Fluticasone furoate. Drug1 is resolved to methylprednisolone, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Methylprednisolone and Fluticasone propionate.
Drug1 (rxcui = 313096, name = spironolactone 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to spironolactone, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Spironolactone and Salmeterol.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Macrobid 100 MG Oral Capsule
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug1 is resolved to aspirin, Drug2 is resolved to nitrofurantoin and interaction asserted in DrugBank between Acetylsalicylic acid and Nitrofurantoin. Drug1 is resolved to aspirin, Drug2 is resolved to nitrofurantoin, macrocrystals and interaction asserted in DrugBank between Acetylsalicylic acid and Nitrofurantoin.
Drug1 (rxcui = 312086, name = ondansetron 8 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to ondansetron, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Ondansetron and Salmeterol. Drug1 is resolved to ondansetron, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Ondansetron and Fluticasone furoate. Drug1 is resolved to ondansetron, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Ondansetron and Fluticasone. Drug1 is resolved to ondansetron, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Ondansetron and Fluticasone propionate.
Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to albuterol, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Salbutamol and Fluticasone. Drug1 is resolved to albuterol, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Salbutamol and Fluticasone furoate. Drug1 is resolved to albuterol, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Salbutamol and Fluticasone propionate. Drug1 is resolved to albuterol, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Salbutamol and Salmeterol.
Applies to: omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet <> Macrobid 100 MG Oral Capsule
Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug1 is resolved to omeprazole, Drug2 is resolved to nitrofurantoin, macrocrystals and interaction asserted in DrugBank between Omeprazole and Nitrofurantoin.
Applies to: Methylprednisolone 4 MG Oral Tablet <> Levofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 259966, name = methylprednisolone 4 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to methylprednisolone, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Methylprednisolone and Levofloxacin. Drug1 is resolved to methylprednisolone, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Methylprednisolone and Levofloxacin.
Drug1 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug2 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to fluticasone, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Fluticasone and Levofloxacin. Drug1 is resolved to salmeterol, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Salmeterol and Levofloxacin. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Fluticasone propionate and Levofloxacin. Drug1 is resolved to fluticasone, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Fluticasone and Levofloxacin. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to levofloxacin and interaction asserted in DrugBank between Fluticasone propionate and Levofloxacin. Drug1 is resolved to salmeterol, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Salmeterol and Levofloxacin. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to levofloxacin anhydrous and interaction asserted in DrugBank between Fluticasone furoate and Levofloxacin.
Drug1 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to oxycodone, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Oxycodone and Fluticasone furoate. Drug1 is resolved to oxycodone, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Oxycodone and Fluticasone. Drug1 is resolved to oxycodone, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Oxycodone and Salmeterol. Drug1 is resolved to oxycodone, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Oxycodone and Fluticasone propionate.
Applies to: albuterol 0.83 MG/ML (albuterol sulfate 1 MG/ML) Inhalant Solution <> Macrobid 100 MG Oral Capsule
Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug1 is resolved to albuterol, Drug2 is resolved to nitrofurantoin, macrocrystals and interaction asserted in DrugBank between Salbutamol and Nitrofurantoin. Drug1 is resolved to albuterol, Drug2 is resolved to nitrofurantoin and interaction asserted in DrugBank between Salbutamol and Nitrofurantoin.
Applies to: Clonidine Hydrochloride 0.3 MG Oral Tablet <> Metoprolol Tartrate 50 MG Oral Tablet
Drug1 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to clonidine, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Clonidine and Metoprolol.
Drug1 (rxcui = 884189, name = clonidine hydrochloride 0.3 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 896185, name = 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Advair], tty = SBD). Drug1 is resolved to clonidine, Drug2 is resolved to salmeterol and interaction asserted in DrugBank between Clonidine and Salmeterol. Drug1 is resolved to clonidine, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Clonidine and Fluticasone furoate. Drug1 is resolved to clonidine, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Clonidine and Fluticasone. Drug1 is resolved to clonidine, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Clonidine and Fluticasone propionate.
Applies to: oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet <> Metoprolol Tartrate 50 MG Oral Tablet
Drug1 (rxcui = 1049221, name = acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to acetaminophen, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Acetaminophen and Metoprolol.
Applies to: Levofloxacin 500 MG Oral Tablet <> Macrobid 100 MG Oral Capsule
Drug1 (rxcui = 199885, name = levofloxacin 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 539712, name = nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule [Macrobid], tty = SBD). Drug1 is resolved to levofloxacin, Drug2 is resolved to nitrofurantoin, macrocrystals and interaction asserted in DrugBank between Levofloxacin and Nitrofurantoin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.